p erbb3 Search Results


90
CH Instruments erbb3 p.y86h
Mutations with significant difference in frequency between pathCR and non-pathCR patients.
Erbb3 P.Y86h, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/p+erbb3/erbb3+p+y86h/pmc06036453-317-6-8
Average 90 stars, based on 1 article reviews
erbb3 p.y86h - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004) [Alexa Fluor® 594]
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004) [Alexa Fluor® 647]
  Buy from Supplier

N/A
The ErbB3/Her3 [p Tyr1328] Antibody from Novus is a ErbB3/Her3 antibody to ErbB3/Her3. This antibody reacts with Human, Mouse, Rat. The ErbB3/Her3 antibody has been validated for the following applications: Western Blot, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence,
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004) [DyLight 755]
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004) [mFluor Violet 450 SE]
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004) [Alexa Fluor® 532]
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004) [Alexa Fluor® 700]
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004) [Alexa Fluor® 750]
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004) [DyLight 350]
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004)
  Buy from Supplier

N/A
ErbB3/Her3 [p Tyr1289] Antibody (0004) [Alexa Fluor® 350]
  Buy from Supplier

Image Search Results


Mutations with significant difference in frequency between pathCR and non-pathCR patients.

Journal: Oncology Letters

Article Title: Aneuploidy of chromosome 8 and mutation of circulating tumor cells predict pathologic complete response in the treatment of locally advanced rectal cancer

doi: 10.3892/ol.2018.8831

Figure Lengend Snippet: Mutations with significant difference in frequency between pathCR and non-pathCR patients.

Article Snippet: The most significant two SNVs were ERBB3 p.Y86H (Chi-square, P=0.0004) and AMER1 p.V490D (Chi-square, P=0.0008).

Techniques: